Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1973 2
1975 1
1981 2
2000 1
2005 2
2008 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Management of intermediate coronary syndrome: role of conservative treatment, glycoprotein IIb/IIIa receptor inhibitors, and direct intervention.
Robertson GC. Robertson GC. Am J Cardiol. 2000 Mar 9;85(5A):21B-26B. doi: 10.1016/s0002-9149(00)00808-0. Am J Cardiol. 2000. PMID: 11076127 Review.
Mortality rates in patients after myocardial infarction (MI) have decreased from a high of >50% in the 1930s to 10-15% currently, and even lower in some clinical trials. At present, much of the research is focused on (1) identifying patients at high risk despite the lac …
Mortality rates in patients after myocardial infarction (MI) have decreased from a high of >50% in the 1930s to 10-15% currently, and eve …
Use of secondary prevention drug therapy in patients with acute coronary syndrome after hospital discharge.
Lee HY, Cooke CE, Robertson TA. Lee HY, et al. J Manag Care Pharm. 2008 Apr;14(3):271-80. doi: 10.18553/jmcp.2008.14.3.271. J Manag Care Pharm. 2008. PMID: 18439049 Free PMC article.
Women were less likely than men to receive statins (P = 0.004) and all 3 drug classes (P = 0.012). Patients with intermediate coronary syndrome were significantly less likely than those with acute myocardial infarction to receive any of the study drugs (P &lt …
Women were less likely than men to receive statins (P = 0.004) and all 3 drug classes (P = 0.012). Patients with intermediate coro …
Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.
Telford AM, Wilson C. Telford AM, et al. Lancet. 1981 Jun 6;1(8232):1225-8. doi: 10.1016/s0140-6736(81)92399-0. Lancet. 1981. PMID: 6112564 Clinical Trial.
A randomised, double-blind, placebo controlled study of morbidity and mortality was carried out using heparin, atenolol, and a combination of both drugs, in 214 patients with the intermediate coronary syndrome. ...These results show that intravenous he …
A randomised, double-blind, placebo controlled study of morbidity and mortality was carried out using heparin, atenolol, and a combin …
Total first-year costs of acute coronary syndrome in a managed care setting.
Etemad LR, McCollam PL. Etemad LR, et al. J Manag Care Pharm. 2005 May;11(4):300-6. doi: 10.18553/jmcp.2005.11.4.300. J Manag Care Pharm. 2005. PMID: 15871640 Free PMC article.
ACS was defined as an emergency room visit or hospitalization with a primary International Classification of Diseases, 9th Edition/Revision (ICD-9) diagnosis of 410.xx (acute myocardial infarction) or 411.1x (intermediate coronary syndrome). Patients were req …
ACS was defined as an emergency room visit or hospitalization with a primary International Classification of Diseases, 9th Edition/Revision …
Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients.
Hendrix KH, Mayhan S, Lackland DT, Egan BM. Hendrix KH, et al. Am J Hypertens. 2005 Aug;18(8):1026-32. doi: 10.1016/j.amjhyper.2005.02.016. Am J Hypertens. 2005. PMID: 16109315
BACKGROUND: Prevalence of chest pain syndromes (CPS)-chest pain, angina pectoris, chronic angina, and preinfarction angina/intermediate coronary syndrome (ICS)-among hypertensive patients and medical management of these disorders in primary care are not well …
BACKGROUND: Prevalence of chest pain syndromes (CPS)-chest pain, angina pectoris, chronic angina, and preinfarction angina/intermediate …
The intermediate coronary syndrome.
Scanlon PJ. Scanlon PJ. Prog Cardiovasc Dis. 1981 Mar-Apr;23(5):351-64. doi: 10.1016/0033-0620(81)90021-9. Prog Cardiovasc Dis. 1981. PMID: 6971456 No abstract available.
Editorial: Intermediate coronary syndrome.
[No authors listed] [No authors listed] Br Med J. 1973 Sep 22;3(5881):601-2. doi: 10.1136/bmj.3.5881.601. Br Med J. 1973. PMID: 4148257 Free PMC article. No abstract available.
Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome.
Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q. Bhurke SM, et al. Pharmacotherapy. 2012 Sep;32(9):809-18. doi: 10.1002/j.1875-9114.2012.01112.x. Epub 2012 Jun 28. Pharmacotherapy. 2012. PMID: 22744772 Free PMC article.
MEASUREMENTS AND MAIN RESULTS: Data were collected on baseline patient demographic and clinical characteristics. Patients were followed from their first clopidogrel prescription until they experienced an adverse cardiovascular event, defined as inpatient hospitalization or …
MEASUREMENTS AND MAIN RESULTS: Data were collected on baseline patient demographic and clinical characteristics. Patients were follow …
11 results